NO139479B - PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DIHALOGEN-PHENYL-ETHANOLAMINES - Google Patents

PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DIHALOGEN-PHENYL-ETHANOLAMINES Download PDF

Info

Publication number
NO139479B
NO139479B NO74743946A NO743946A NO139479B NO 139479 B NO139479 B NO 139479B NO 74743946 A NO74743946 A NO 74743946A NO 743946 A NO743946 A NO 743946A NO 139479 B NO139479 B NO 139479B
Authority
NO
Norway
Prior art keywords
general formula
amino
phenyl
hal
ethanolamines
Prior art date
Application number
NO74743946A
Other languages
Norwegian (no)
Other versions
NO743946L (en
NO139479C (en
Inventor
Johannes Keck
Gerd Krueger
Helmut Pieper
Klaus-Reinhold Noll
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO743946L publication Critical patent/NO743946L/no
Publication of NO139479B publication Critical patent/NO139479B/en
Publication of NO139479C publication Critical patent/NO139479C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline

Description

Denne oppfinnelse angår en ny fremgangsmåte for fremstilling av 4-amino-3,5-dihalogen-fenyl-etanolaminer med den generelle formel I This invention relates to a new process for the production of 4-amino-3,5-dihalo-phenyl-ethanolamines of the general formula I

hvor Hal betyr et klor- eller bromatom og where Hal means a chlorine or bromine atom and

R betyr en alkyl- eller cykloalkylrest med 3 til 5 karbonatomer, R means an alkyl or cycloalkyl radical with 3 to 5 carbon atoms,

og deres fysiologisk forlikelige syreaddisjonssalter med uorganiske eller organiske syrer. and their physiologically compatible acid addition salts with inorganic or organic acids.

Forbindelsene med den ovenstående generelle formel I og The compounds of the above general formula I and

deres syreaddisjonssalter er i besittelse av verdifulle farmakologiske egenskaper, særlig en virkning på &-reseptorene. their acid addition salts possess valuable pharmacological properties, particularly an action on the & receptors.

Det er nu overraskende funnet at forbindelsene med den ovenstående generelle formel I kan fremstilles med utmerkede ut- It has now surprisingly been found that the compounds of the above general formula I can be prepared with excellent

bytter også efter følgende fremgangsmåte: also change according to the following procedure:

Omsetning av en ny forbindelse med den generelle formel Substitution of a new compound with the general formula

hvor Hal er som ovenfor angitt, eller et hydrat derav, med et amin med den generelle formel III hvor R er som ovenfor angitt, til en Schiffsk base med den generelle formel IV where Hal is as above, or a hydrate thereof, with an amine of the general formula III where R is as above, to a Schiff base of the general formula IV

hvor Hal og R er som ovenfor angitt, som derefter reduseres. where Hal and R are as stated above, which are then reduced.

Omsetningen utføres hensiktsmessig i et oppløsningsmiddel så som metanol, etanol, dioksan, i benzen eller toluen under anvendelse av en vannutskiller eller i et overskudd av det anvendte amin med den generelle formel III. Reduksjonen av forbindelsen med formel IV kan foretas med et reduksjonsmiddel så som katalytisk dannet hydrogen, f.eks. med hydrogen i nærvær av Raney-nikkel eller Raney-kobolt, med nascerende hydrogen, f.eks. med aktivert, metallisk aluminium og vann, med natriumamalgam og etanol, med sink og saltsyre, eller med et komplekst metallhydrid, f.eks. med natriumborhydrid eller litiumaluminiumhydrid i et egnet opp-løsningsmiddel så som metanol, etanol, etanol/vann, eter, tetrahydrofuran, dioksan eller dioksan/vann og fortrinnsvis ved temperaturer mellom 0 og 115°C, f.eks. ved temperaturer opp til det anvendte oppløsningsmiddels koketemperatur. The reaction is suitably carried out in a solvent such as methanol, ethanol, dioxane, in benzene or toluene using a water separator or in an excess of the amine of the general formula III used. The reduction of the compound of formula IV can be carried out with a reducing agent such as catalytically formed hydrogen, e.g. with hydrogen in the presence of Raney nickel or Raney cobalt, with nascent hydrogen, e.g. with activated metallic aluminum and water, with sodium amalgam and ethanol, with zinc and hydrochloric acid, or with a complex metal hydride, e.g. with sodium borohydride or lithium aluminum hydride in a suitable solvent such as methanol, ethanol, ethanol/water, ether, tetrahydrofuran, dioxane or dioxane/water and preferably at temperatures between 0 and 115°C, e.g. at temperatures up to the boiling temperature of the solvent used.

De erholdte forbindelser med den generelle formel I kan eventuelt overføres til de fysiologisk forlikelige syreaddisjonssalter med uorganiske eller organiske syrer. Særlig egnede syrer er f.eks. saltsyre, bromhydrogensyre, svovelsyre, fosforsyre, melkesyre, sitronsyre, vinsyre, maleinsyre eller fumarsyre. The obtained compounds of the general formula I can optionally be transferred to the physiologically compatible acid addition salts with inorganic or organic acids. Particularly suitable acids are e.g. hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, lactic acid, citric acid, tartaric acid, maleic acid or fumaric acid.

En som utgangsmateriale anvendt ny forbindelse med den generelle formel II får man f.eks. ved oksydasjon av et tilsvarende acetofenon med selendioksyd eller ved oksydasjon av et tilsvarende fenylacylbromid med dimetylsulfoksyd. A new compound with the general formula II used as starting material gives, for example, by oxidation of a corresponding acetophenone with selenium dioxide or by oxidation of a corresponding phenyl acyl bromide with dimethyl sulphoxide.

Fremgangsmåten ifølge foreliggende oppfinnelse kunne ikke forutsees da det er almindelig kjent at forbindelser som samtidig inneholder en amino- og en aldehyd-gruppe er ustabil, særlig i nærvær av baser og har en tendens til selvkondensasjon. The method according to the present invention could not be foreseen as it is generally known that compounds which simultaneously contain an amino and an aldehyde group are unstable, particularly in the presence of bases and have a tendency to self-condensate.

De følgende eksempler skal tjene til å illustrere opp-finnelsen ytterligere. The following examples shall serve to further illustrate the invention.

Eksempel A Example A

4-amino-3, 5- diklor- fenylglyoksal- hydrat 4-amino-3, 5-dichloro-phenylglyoxal- hydrate

40,8 g 4-amino-3,5-diklor-acetofenon settes porsjonsvis under omrøring til en 60-70°C varm oppløsning av 22,2 g selendioksyd i 200 ml dioksan og 6 ml vann. Efter 4 timers koking under tilbakeløpskjøling lar man blandingen avkjøles, tilsetter noe aktivt kull, filtrerer og inndamper i vannstrålevakuum. Residuet oppløses i etylacetat-benzen (1:4), tilsettes noe cykloheksan til begynnende uklarhet, filtreres og får stå i 2 dager ved rom-temperatur til langsom krystallisasjon av 4-amino-3,5-diklor-fenylglyoksal-hydratet. 40.8 g of 4-amino-3,5-dichloro-acetophenone is added in portions while stirring to a 60-70°C hot solution of 22.2 g of selenium dioxide in 200 ml of dioxane and 6 ml of water. After 4 hours of boiling under reflux cooling, the mixture is allowed to cool, some activated carbon is added, filtered and evaporated in a water jet vacuum. The residue is dissolved in ethyl acetate-benzene (1:4), some cyclohexane is added to the beginning of cloudiness, filtered and allowed to stand for 2 days at room temperature for slow crystallization of the 4-amino-3,5-dichloro-phenylglyoxal hydrate.

Smeltepunkt: 95-98°C. Melting point: 95-98°C.

Eksempel 1 Example 1

1-( 4- amino- 3, 5- diklor- fenyl)- 2- tert.- butylamino- etanol 1-( 4- amino- 3, 5- dichloro- phenyl)- 2- tert.- butylamino- ethanol

4,7 g (0,02 mol) 4-amino-3,5-diklor-fenylglyoksal-hydrat i 50 ml metanol tilsettes 8,8 g (0,12 mol) tert.-butylamin. Derved oppstår under lett oppvarming først en klar oppløsning, og senere begynner et bunnfall å skille seg ut. Efter 1 times om-røring tilsettes dråpevis en oppløsning av 1,9 g (0,05 mol) natriumborhydrid i 10 ml vann, hvorved bunnfallet oppløser seg under lett oppvarming. Efter 2 timers omrøring tilsettes oppløsningen konsentrert saltsyre dråpevis til sterkt sur reaksjon for å spalte overskudd av natriumborhydrid, oppløsningen filtreres, og for utfélling av 1-(4-amino-3,5-diklor-fenyl)-2-tert.-butylamino-etanol gjøres oppløsningen alkalisk med konsentrert ammoniakk. Utbytte: 4,8 g (86,6% av det teoretiske), sm.p.: 110-118°C. Smeltepunkt for hydrokloridet: 174-175,5°C (spaltning). 4.7 g (0.02 mol) of 4-amino-3,5-dichloro-phenylglyoxal hydrate in 50 ml of methanol is added to 8.8 g (0.12 mol) of tert-butylamine. Thereby, under light heating, a clear solution first occurs, and later a precipitate begins to separate. After stirring for 1 hour, a solution of 1.9 g (0.05 mol) of sodium borohydride in 10 ml of water is added dropwise, whereby the precipitate dissolves under slight heating. After stirring for 2 hours, concentrated hydrochloric acid is added dropwise to the solution to a strongly acidic reaction to split excess sodium borohydride, the solution is filtered, and to precipitate 1-(4-amino-3,5-dichloro-phenyl)-2-tert-butylamino- ethanol, the solution is made alkaline with concentrated ammonia. Yield: 4.8 g (86.6% of theory), mp: 110-118°C. Melting point of the hydrochloride: 174-175.5°C (decomposition).

Eksempel 2 Example 2

1-( 4- amino- 3, 5- diklor- fenyl)- 2- cyklopropylamino- etanol Smeltepunkt: 125-127°C. 1-(4-amino-3,5-dichloro-phenyl)-2-cyclopropylamino-ethanol Melting point: 125-127°C.

Fremstilt fra 4-amino-3,5-diklor-fenylglyoksal-hydrat, cyklo-propylamin og natriumborhydrid analogt med eksempel 1. Prepared from 4-amino-3,5-dichloro-phenylglyoxal hydrate, cyclopropylamine and sodium borohydride analogously to example 1.

Eksempel 3 Example 3

1-( 4- amino- 3, 5- diklor- fenyl)- 2- cyklobutylamino- etanol Smeltepunkt for hydrokloridet: 184-184,5°C (spaltning). 1-(4-amino-3,5-dichloro-phenyl)-2-cyclobutylamino-ethanol Melting point for the hydrochloride: 184-184.5°C (decomposition).

Fremstilt fra 4-amino-3,5-diklor-fenylglyoksal-hydrat, cyklobutyl-amin og natriumborhydrid analogt med eksempel 1. Prepared from 4-amino-3,5-dichloro-phenylglyoxal hydrate, cyclobutylamine and sodium borohydride analogously to example 1.

Eksempel 4 Example 4

1-( 4- amino- 3, 5- diklor- fenyl)- 2^ cyklopentylamino- etanol Smeltepunkt for hydrokloridet: 148-150 C (spaltning). 1-(4-amino-3,5-dichloro-phenyl)-2^cyclopentylamino-ethanol Melting point for the hydrochloride: 148-150 C (decomposition).

Fremstilt fra 4-amino-3,5-diklor-fenylglyoksal-hydrat, cyklopentyl-amin og natriumborhydrid analogt med eksempel 1. Prepared from 4-amino-3,5-dichloro-phenylglyoxal hydrate, cyclopentyl amine and sodium borohydride analogously to example 1.

Claims (1)

Fremgangsmåte for fremstilling av 4-amino-3,5-dihalogen- •Process for the production of 4-amino-3,5-dihalo- • fenyl-etanolaminer med den generelle formel Iphenyl-ethanolamines of the general formula I hvor Hal betyr et klor- eller bromatom, og R betyr en alkyl- eller cykloalkylrest med 3 til 5 karbonatomer,where Hal means a chlorine or bromine atom, and R means an alkyl or cycloalkyl radical with 3 to 5 carbon atoms, og deres fysiologisk forlikelige syreaddisjonssalter med uorganiske eller organiske syrer, karakterisert ved at en forbindelse med den generelle formel IIand their physiologically compatible acid addition salts with inorganic or organic acids, characterized in that a compound of the general formula II hvor Hal er som ovenfor angitt, eller et hydrat derav, omsettes med et amin med den generelle formel III,where Hal is as indicated above, or a hydrate thereof, is reacted with an amine of the general formula III, hvor R er som ovenfor angitt, til en Schiffsk base med den generelle formel IVwhere R is, as indicated above, a Schiff base of the general formula IV hvor Hal og R har den ovenfor angitte betydning, som derefter reduseres, hvorefter man om ønsket overfører den dannede forbindelse med den generelle formel I i et fysiologisk akseptabelt syre-addis jonssalt derav.where Hal and R have the meaning indicated above, which is then reduced, after which, if desired, the formed compound of the general formula I is transferred into a physiologically acceptable acid addition salt thereof.
NO743946A 1973-11-02 1974-11-01 PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DIHALOGEN-PHENYL-ETHANOLAMINES NO139479C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2354959A DE2354959C3 (en) 1973-11-02 1973-11-02 New process for the preparation of 4-amino-3,5 dihalo phenyl-athanolamines

Publications (3)

Publication Number Publication Date
NO743946L NO743946L (en) 1975-05-26
NO139479B true NO139479B (en) 1978-12-11
NO139479C NO139479C (en) 1979-03-21

Family

ID=5897109

Family Applications (1)

Application Number Title Priority Date Filing Date
NO743946A NO139479C (en) 1973-11-02 1974-11-01 PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DIHALOGEN-PHENYL-ETHANOLAMINES

Country Status (19)

Country Link
JP (1) JPS5855133B2 (en)
AT (1) AT340394B (en)
BG (1) BG23746A3 (en)
CA (1) CA1041545A (en)
CH (1) CH609040A5 (en)
CS (1) CS175487B2 (en)
DD (1) DD116599A5 (en)
DE (1) DE2354959C3 (en)
DK (1) DK134484C (en)
ES (1) ES430587A1 (en)
FI (1) FI60858C (en)
HU (1) HU168133B (en)
NL (1) NL7414223A (en)
NO (1) NO139479C (en)
PL (1) PL96537B1 (en)
RO (1) RO68703A (en)
SE (2) SE411546B (en)
SU (1) SU549079A3 (en)
YU (1) YU36918B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714484A1 (en) * 1987-04-30 1988-11-10 Bayer Ag NEW AMINOPHENYLETHYLAMINE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS A PERFORMANCE PROVIDER
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
WO2017021982A1 (en) * 2015-08-06 2017-02-09 Vamsi Labs Ltd. A PROCESS FOR PREPARING β AGONIST
CN111393311A (en) * 2020-03-30 2020-07-10 苏州弘森药业股份有限公司 Environment-friendly and nontoxic synthesis method of clenbuterol hydrochloride

Also Published As

Publication number Publication date
DE2354959C3 (en) 1980-02-07
NO743946L (en) 1975-05-26
ATA756374A (en) 1977-04-15
BG23746A3 (en) 1977-10-12
PL96537B1 (en) 1977-12-31
DD116599A5 (en) 1975-12-05
DE2354959A1 (en) 1975-05-15
CH609040A5 (en) 1979-02-15
FI273674A (en) 1975-05-03
YU36918B (en) 1984-08-31
HU168133B (en) 1976-02-28
AT340394B (en) 1977-12-12
SE411546B (en) 1980-01-14
RO68703A (en) 1981-09-24
CA1041545A (en) 1978-10-31
YU285074A (en) 1982-06-18
DK552274A (en) 1975-06-23
SU549079A3 (en) 1977-02-28
NL7414223A (en) 1975-05-07
ES430587A1 (en) 1976-09-01
SE7413786L (en) 1975-05-05
JPS5071637A (en) 1975-06-13
FI60858B (en) 1981-12-31
CS175487B2 (en) 1977-05-31
NO139479C (en) 1979-03-21
SE7708686L (en) 1977-07-28
FI60858C (en) 1982-04-13
DE2354959B2 (en) 1979-06-07
DK134484B (en) 1976-11-15
SE430057B (en) 1983-10-17
JPS5855133B2 (en) 1983-12-08
DK134484C (en) 1977-04-25

Similar Documents

Publication Publication Date Title
SU649312A3 (en) Method of obtaining 4-(polyalkoxyphenyl)-2-pyrrolidones
FI76568C (en) Process for the preparation of therapeutically active substituted imide azole derivatives
HU193161B (en) Process for preparing new n-alkyl-norscopines
SU537627A3 (en) Method for producing morpholine derivatives
Henry et al. 1, 3-and 1, 4-Dialkyl-5-iminotetrazoles
SE452610B (en) SETTING DIVERSE RACEMIC CIS-1,2-CYCLOPROPANDICARBOXYLIC ACID DERIVATIVES
NO139479B (en) PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DIHALOGEN-PHENYL-ETHANOLAMINES
EP0130224B1 (en) Process for the preparation of 2-amino-3,5-dibromobenzyl amines
NO138408B (en) COMPOUND FOR USE AS A STARTING MATERIAL FOR THE PREPARATION OF 1- (4-METZYL-6-METHOXY-2-PYRIMIDINYL) -3-METHYL-5-METHOXYPYRAZOLE, AND PROCEDURE FOR PREPARING
JPS5924145B2 (en) Method for producing 1-methyl-3,5-diphenylpyrazole
JPH0458468B2 (en)
US2715129A (en) Process for producing 5-hydroxytryptamine
US4251659A (en) Polyfluorohydroxyisopropyl-heterocyclic compounds
US3450709A (en) Process for the preparation of ring-substituted 2-aminoimidazoles
CA1040656A (en) Phenoxyalkylamine derivatives and preparation thereof
JPS60202859A (en) 3-aminoazetidin compound and manufacture
Burger et al. Amino Derivatives of 2, 2-Diphenylcyclohexanone. I1
US3733338A (en) 1-oxo-isochromenes
US3375247A (en) Heterocyclic compounds and methods for their production
US2782191A (en) Nitrogen containing carbinols
Kirschke et al. Surprising reactions or special azoolefins-self-arylation, indole ring closure, mild chlorine substitution, and “tert. amino effect”
DK148278B (en) PHENYLGLYOXYL DERIVATIVE OR A HYDRATE THEREOF USED AS AN INTERMEDIATE PRODUCT BY THE PREPARATION OF PHENYLETHANOLE DERIVATIVES OR ACID ADDITION SALTS
NO144099B (en) MACHINE FOR MACHINE FLAMMING OF SOME DEFECTS ON THE SURFACE OF A METAL BODY
Huber et al. Some dialkylaminoalkylamines
KR790001737B1 (en) New process for the preparation of 4-amino-3,5-dihalogen-phenyl-ethanol amines